Skip to main content

Most Importantly, Anne Has the "Likes Brussels Sprouts" Gene

Fast Company has an interview with 23andMe co-founders, Linda Avey and Anne Wojcicki. Mostly they talk about using genetic testing information to form social networks and to give people the opportunity to connect on different, possibly deeper, levels as per health-related concerns. "Part of the thing that really motivated me in getting into this was adverse events," Avey says. "I would love to have cancer patients be able to walk in five years from now and get their tumor genotyped and know they should be taking this kind of drug instead of that one."

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.